1. CTIM-35. A PHASE II STUDY OF GITR AGONIST INCAGN01876 AND PD-1 INHIBITOR RETIFANLIMAB IN COMBINATION WITH STEREOTACTIC RADIOTHERAPY IN PATIENTS WITH RECURRENT GLIOBLASTOMA. (14th November 2022) Authors: Bagley, Stephen; Shabason, Jacob; Mathew, Divij; Kothari, Shawn; Oldridge, Derek; Desai, Arati; Lustig, Robert; Kurtz, Goldie; Alonso-Basanta, Michelle; Chen, Kan; Long, Qi; Harsch, Jessica; Salman, Muhammad; Fernandez, Peter; Monsour, Maikel; Prior, Timothy; Maloney, Eileen; MacMurtrie, Eileen; ... Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗